India & Sun Pharma
9 shared events · Importance 3 · Last updated May 27, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
India: Domestic markets in India closed higher, supported by global cues, US labor data, and positive outcomes from the India-Japan Summit.
Sun Pharma: Sun Pharma was among the winning stocks, contributing to the overall market gains.
Jul 03, 2026 · 7 articles
Business
India: India is a key battleground for weight-loss drugs due to its large obesity population and is experiencing significant competition between Novo Nordisk and Eli Lilly and Company.
Sun Pharma: Sun Pharma is among the Indian generic drugmakers expected to introduce lower-priced versions of semaglutide after Semaglutide's patent expires.
Nov 11, 2025 · 6 articles
International
Sun Pharma: Sun Pharma was among the firms that saw declines in the S&P BSE Sensex.
Jan 08, 2026 · 7 articles
NEWSDESK
Explore this relationship live
Track how India and Sun Pharma interact across events, view sentiment trends, and discover connected entities.
Open Dashboard